Ketamine for Crohn's Disease

 

Ketamine for Crohn's Disease Summary

Research into Ketamine for pain management shows it to be a safe alternative to opioids in emergency settings. A 2025 study has shown that 20-46% of patients achieved clinically meaningful improvements in pain management and found the benefits were sustained 6 months post treatment. A 2025 study found Ketamine to match the effect of opioids for immediate pain relief without the side effects. Overall the studies show that Ketamine is an effective tool for treating pain.

Crohn's disease is a chronic, autoimmune inflammatory bowel disease causing inflammation anywhere along the digestive tract, most commonly the small intestine and colon. One of the key symptoms of Crohn's disease is abdominal pain. Ketamine is currently being explored for symptom control, by using it to control pain and inflammation related pathways.

1) Mechanism of Action

Ketamine is used as an analgesic, especially for severe acute pain and selected chronic pain syndromes.

  • NMDA receptor antagonism causes a reduction in glutamate-mediated pain transmission
  • Decreases central sensitization
  • Reduction in pro-inflammatory cytokines (e.g., TNF-α, IL-6)
  • Modulation of the gut-brain axis.

These effects can help patients with chronic abdominal pain.

2) Clinical Indications

  • Refractory abdominal pain in Crohn's disease
  • Patients with chronic pain
  • Opioid-tolerant or opioid-resistant pain

Ketamine is often used as an adjunct rather than a first-line analgesic, but does not treat the underlying disease itself

3) Clinical Effects

  • Improved pain control in opioid-resistant cases
  • Decreased visceral hypersensitivity
  • Reduction in abdominal pain intensity
  • Improved quality of life

In chronic pain, ketamine may sometimes provide relief that lasts beyond the infusion period by helping reset abnormal pain processing and can last for days and even weeks after the ketamine session. Repeated infusions can prolong the benefit.

4) Potential Advantages

  • Targets central pain mechanisms
  • Useful in opioid resistant abdominal pain
  • May reduce opioid dependency
  • May produce longer lasting relief

5) Limitations and Risks

  • Does not treat the disease itself, just helps with the pain
  • Short duration of benefit in some cases
  • Need for monitoring at higher doses
  • Potential for misuse or dependence

6) Adverse Effects

  • Dissociation
  • Hallucinations or perceptual disturbances
  • Dizziness
  • Nausea/vomiting
  • Sedation
  • Increased blood pressure and heart rate

With repeated or long-term use

  • Cystitis (ketamine bladder syndrome)
  • Cognitive effects
  • Potential hepatotoxicity

7) Current Clinical Role

  • Not part of standard Crohn's disease treatment
  • Reserved for treating refractory abdominal pain
  • Typically used as an adjunct to other analgesics